U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07076082) titled 'Vascular Trial Associated Registry Pilot' on July 17.
Brief Summary: The purpose of this investigator-initiated, multicenter, open label, randomized trial is to evaluate 1 month vs. 6 months of dual antiplatelet therapy (DAPT) in patients undergoing lower extremity endovascular revascularization. We hypothesize that extending dual antiplatelet therapy (DAPT) to six months, compared to one month, will improve patency rates of target vessels following peripheral vascular intervention (PVI) without significantly increasing complications, particularly bleeding events.
Study Start Date: Aug. 30
Study Type: INTERVENTIONAL
Condition:
P...